Teladoc Health (TDOC) Cash from Financing Activities (2014 - 2026)

Teladoc Health (TDOC) has 13 years of Cash from Financing Activities data on file, last reported at -$2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Financing Activities fell 418.47% year-over-year to -$2.4 million; the trailing twelve-month figure through Mar 2026 stood at -$554.9 million (down 7669.85% YoY), and the FY2025 full-year result was -$551.7 million, down 6736.81% from the prior year.
• Cash from Financing Activities fell to -$2.4 million in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $5.1 million in Q3 2023 to a low of -$549.9 million in Q2 2025.
• A 5-year average of -$31.1 million and a median of $1.1 million in 2025 frame the typical range for Cash from Financing Activities.
• Across the five-year window, Cash from Financing Activities surged 699.37% in 2023 and plunged 14552.9% in 2025, its largest moves.
• Tracing TDOC's Cash from Financing Activities over 5 years: stood at $4.4 million in 2022, then sank by 140.52% to -$1.8 million in 2023, then surged by 215.94% to $2.1 million in 2024, then tumbled by 46.36% to $1.1 million in 2025, then slumped by 321.83% to -$2.4 million in 2026.
• Business Quant data shows TDOC's Cash from Financing Activities at -$2.4 million in Q1 2026, $1.1 million in Q4 2025, and -$3.6 million in Q3 2025.